Comparison

Ibrolipim European Partner

Item no. TMO-T7832-200mg
Manufacturer TargetMol
CASRN 133208-93-2
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles CCOP(=O)(Cc1ccc(cc1)C(=O)Nc1ccc(Br)cc1C#N)OCC
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias NO-1886
Shipping Condition Cool pack
Available
Manufacturer - Targets
LPL Receptor
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
451.25
Description
Ibrolipim (NO-1886) attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.
Pathways
GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close